Drug Delivery

Abstract Aim: Dasatinib (DST) is an oral tyrosine kinase inhibitor with poor aqueous solubility. To outwit this issue, a solid self-nano...

Guanfacine (GFC) extended-release tablet (Intuniv®) is an effective non-stimulant medication prescribed for attention deficit hyperactivity disorder (ADHD), presenting limitations regarding...

About 90% of active pharmaceutical ingredients (APIs) in the oral drug delivery system pipeline have poor aqueous solubility and low...

Abstract The pharmaceutical industry is progressing swiftly, driven by innovations that have led to the discovery of novel active pharmaceutical...

Abstract Neratinib maleate (NM), a tyrosine kinase inhibitor, is used in the treatment of breast cancer. NM is orally administered...

Extracellular vesicles (EVs) have emerged as a promising drug delivery system. Connectosomes are a specialized type of EVs that contain...

Abstract Recently, transmucosal drug delivery systems (TDDSs) have been extensively studied because they protect therapeutic agents from degradation; improve drug...

Abstract The liquisolid system of drug delivery continues to find usefulness as a potent means to circumvent solubility and dissolution...

Abstract Drug delivery is essential to provide correct treatments in many ways. The critical points in any drug delivery method...

Abstract Block copolymer micelles, formed by the self-assembly of amphiphilic polymers, address formulation challenges, such as poor drug solubility and...